> CLINICAL RESULTS
Immediate efficacy
- Spreads easier than competitors(1) allowing less friction on the skin during cleansing (for 100% of subjects(2))
- Skin is gently cleansed (for 100% of subjects(2))
- Skin is immediately soothed and feels comfortable, less tight (for 100% of subjects(2))
- 24h hydration(3)
After 28 days of use
- Moisturises the skin (+53.1% hydration level(2))
- Skin is hydrating lastingly (for 86% of subjects(2))
- Skin is soothed lastingly (for 90% of subjects(2))
- Skin is nourished lastingly (for 93% of subjects(2)). Sébium Hydra cleanser provides 24h comfort (for 91% of subjects(4))
- Preserves lipids rate on skin(2) without impacting efficacy of dermatological treatment
- Preserves skin pH(5)
TOLERANCE
Sébium Hydra cleanser demonstrated a very high cutaneous and ocular tolerance(2)
> PATIENTS FEEDBACKS
In combination with dermatological treatment, after 28 days of use, 80% of subjects have an improvement of their acne(2). Perfectly cleansed(2) and immediately soothed(2), the skin is nourished(2), moisturised for 24h(3) and regains long-lasting comfort(4).
Sébium Hydra cleanser helps the skin to restore its natural balance weakened by dermatological treatments by providing comfort as soon as the cleansing step.
(1) Measurement of viscosity by rheometer (physical parameter) under different shear stresses of Sebium Hydracleanser in comparison to Effaclar H & Effaclar Iso-biome cleansing cream (La Roche Posay), Soothing Cleansing Cream Cleanance Hydra (Avène), France, 2022.
(2) Clinical study on 30 subjects aged from 14 to 30 years old with mild to moderate acne with very dry skin under topical or oral treatment (retinoic acid or isotretinoin) after 28 days of twice daily application in addition to their usual daily cream, Portugal, 2023.
(3) Measurement of hydration level by corneometry on 12 subjects 24h after the last application, France, 2022
(4) Evaluation of efficacy and comedogenic potential on 33 subjects aged from 21 to 42 years old with acne-prone skin immediately and 28 days after twice daily use by self-assessement (% of satisfaction). Argentina, 2022
(5) Measurement of skin pH on 10 subjects, aged from 32 to 64 years old after 28 days of twice daily use, France, 2022
(1) Clinical study on 30 subjects aged from 14 to 30 years old with mild to moderate acne with very dry skin under topical or oral treatment (retinoic acid or isotretinoin) after 28 days of twice daily application in addition to their usual daily cream, Portugal, 2023.
(2) Measurement of hydration level by corneometry on 12 subjects 24h after the last application, France, 2022
(3) Evaluation of efficacy and comedogenic potential on 33 subjects aged from 21 to 42 years old with acne-prone skin immediately and 28 days after twice daily use by self-assessement (% of satisfaction). Argentina, 2022
(4) Measurement of skin pH on 10 subjects, aged from 32 to 64 years old after 28 days of twice daily use, France, 2022